TheraRadar
Clinical-Stage Companies / Grünenthal

Grünenthal

Pre-Approval PRO BETA
40
Total Trials
16
Phase 3
10
Phase 2
3
Recruiting
382
Score

Pipeline by Phase

Phase 3
16
Phase 2
10
Phase 1
14

Therapeutic Focus

Chronic Pain Pain Osteoarthritis Neuropathic Pain Low Back Pain

Clinical Trials (40)

NCT05449132 Phase 3 COMPLETED

Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the Knee

Started: 9/26/2022

NCT05248386 Phase 3 COMPLETED

Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee Osteoarthritis

Started: 8/26/2022

NCT05377489 Phase 3 COMPLETED

Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the Knee

Started: 9/15/2022

NCT03530345 Phase 3 TERMINATED

Efficacy and Safety of Intravenous Neridronic Acid in CRPS

Started: 5/30/2018

NCT03560986 Phase 3 TERMINATED

Efficacy and Safety of Intravenous Neridronic Acid in Complex Regional Pain Syndrome (CRPS)

Started: 5/31/2018

NCT02081391 Phase 3 COMPLETED

A Study to Look at Tapentadol Oral Solution in Children and Adolescents in Pain

Started: 2/19/2015

NCT02972359 Phase 3 COMPLETED

Safety of Intravenous Neridronic Acid in CRPS

Started: 12/20/2016

NCT01264887 Phase 3 TERMINATED

Tapentadol in Chronic Malignant Tumour Related Pain

Started: 3/1/2011

NCT00983073 Phase 3 COMPLETED

Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking Either WHO Step I or Step II Analgesics or no Regular Analgesic

Started: 9/1/2009

NCT00982280 Phase 3 TERMINATED

Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking WHO Step III Analgesics But Showing a Lack of Tolerability.

Started: 9/1/2009

NCT03714672 Phase 3 COMPLETED

Tramadol/Diclofenac Fixed-dose Combination Phase III Trial in Acute Pain After Third Molar Extraction

Started: 8/26/2017

NCT00983385 Phase 3 COMPLETED

Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics

Started: 9/30/2009

NCT00986258 Phase 3 TERMINATED

Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability

Started: 10/30/2009

NCT01752322 Phase 3 COMPLETED

Efficacy and Tolerability of Lidocaine Plaster for Treatment of Long-term Local Nerve Pain

Started: 10/1/2012

NCT01729728 Phase 2 COMPLETED

Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain

Started: 11/1/2012

NCT01435577 Phase 2 COMPLETED

Intravenous Tapentadol in Post-Bunionectomy Pain

Started: 9/1/2011

NCT01485094 Phase 2 TERMINATED

A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripheral Neuropathic Pain

Started: 2/1/2012

NCT01056315 Phase 2 TERMINATED

A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y

Started: 11/1/2009

NCT01155986 Phase 2 TERMINATED

Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain

Started: 8/1/2010

NCT02151682 Phase 2 COMPLETED

A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain

Started: 4/29/2015

NCT02225353 Phase 2 COMPLETED

Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery

Started: 9/2/2013

NCT02402530 Phase 2 COMPLETED

Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I

Started: 4/1/2015

NCT02221674 Phase 2 TERMINATED

Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years Old

Started: 11/5/2014

NCT01043263 Phase 2 COMPLETED

Efficacy and Safety of EN3324 (Axomadol) in Subjects With Chronic Low Back Pain

Started: 12/1/2009

NCT07479745 Phase 1 RECRUITING

Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019

Started: 3/25/2026

NCT07289776 Phase 1 RECRUITING

A First-in-human Trial of GRT7041 in Healthy Participants

Started: 1/14/2026

NCT07347548 Phase 1 ACTIVE NOT RECRUITING

A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants

Started: 1/6/2026

NCT07317063 Phase 1 COMPLETED

A Trial to Investigate Safety and Pharmacokinetics of GRT6019, Including Food Effect, in Healthy Male Participants

Started: 11/21/2025

NCT02566564 Phase 1 COMPLETED

Intra-articular Lopain (MTX-071) Phase I/IIa Study in Chronic Osteoarthritic Knee Joint Pain

Started: 4/1/2016

NCT03749733 Phase 1 WITHDRAWN

Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol Acetate

Started: 10/1/2019

NCT03905564 Phase 1 WITHDRAWN

A Study to Investigate Differences in the Extent and Rate of Absorption of Doxylamine/Pyridoxine From 2 Different Products Under Fasting Conditions

Started: 6/1/2019

NCT03737656 Phase 1 COMPLETED

Characterization of the Pharmacokinetics of a Vaginal Ring With 2.0 g Progesterone in Post-menopausal Women

Started: 11/1/2018

NCT03767036 Phase 1 COMPLETED

Administration of Tramadol and Ketorolac Separately and Simultaneously to Assess a Potential Pharmacokinetic Interaction

Started: 6/5/2017

NCT03766984 Phase 1 COMPLETED

Pharmacokinetic Non-interaction Study With a Fixed-dose Combination Tablet With Tramadol and Diclofenac

Started: 6/7/2015

NCT03765346 Phase 1 COMPLETED

A Comparison of How Likely it is That Different Tablets of Oxycodone Will be Broken up and Snorted by Adults Who Sometimes Take Drugs for Pleasure

Started: 7/24/2018

NCT03399435 Phase 1 TERMINATED

A Study in Healthy Male Volunteers to Investigate the Safety and Tolerability of a Single Dose of Neosaxitoxin Alone and in Combination With Bupivacaine (With and Without Epinephrine) for Brachial Plexus Blockade

Started: 1/30/2018

NCT03137030 Phase 1 WITHDRAWN

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults

Started: 9/1/2017

NCT03137017 Phase 1 WITHDRAWN

A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults

Started: 9/1/2017

NCT01352741 Phase 4 COMPLETED

Comparison of Increasing Doses of Tapentadol Versus a Combination of Tapentadol and Pregabalin

Started: 3/1/2011

NCT01838616 Phase 4 COMPLETED

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Started: 4/1/2013

Drug Candidates

GRT6019 [14C]GRT6019 RTX-GRT7039 Placebo GRT7041 SAD Midazolam GRT7041 MAD Lopain Neridronic acid 100 mg Tapentadol oral solution 4 mg/mL
Activity Status: Active
Last Trial Started: 3/25/2026
Last Trial Ended: 1/6/2026
Trials (12 months): 4
Completed Trials: 23
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.